Thank you for sharing!

Your article was successfully shared with the contacts you provided.
New legislation now before President Bush could result in $37 billion in new funding over the next five years for the National Science Foundation — money that is expected to boost venture capital investments in nanotechnology and emerging biotech sectors. The legislation, which has been passed by both the House of Representatives and the Senate, is now headed to Bush for final review and a signature. The bill authorizes $5.5 billion in funds for 2003, rising to $9.83 billion by 2007, for the NSF, a primary source of research grants for universities and, in turn, many startup companies. The increased funding is specifically targeting research on campus and startups involved in nanotechnology and plant genome research. “I think this is simply fantastic,” said Bart Schacter, a general partner with San Francisco-based Blueprint Ventures. “The nanotech industry far more than other sectors needs a large government infusion before VCs can seriously become interested in investing in these companies.” The government’s commitment is particularly important given today’s economic climate, added Wendy Chin, managing director in Boston with ITF Global Partners, a boutique investment bank that also runs a $100 million venture capital fund. “VCs really do like to share the risk on investments these days, more so than ever before,” she said. “And they don’t want to be the only ones entering a new and cutting-edge field.” Chin pointed out that many nanotech investments are expected to take 15 years to 20 years before they are able to provide profits for their investors. The new measure would authorize $5.5 billion in funding for fiscal 2003, $6.39 billion for fiscal 2004, $7.37 billion for 2005, $8.52 billion for 2006 and $9.83 billion for 2007, according to the Congressional Quarterly. Jim Tullis, managing partner of Tullis-Dickerson & Co., a Greenwich, Conn.-based fund that targets investments in biomedical and healthcare companies across the United States, said that the government has chosen to support two sectors — nanotechnology and plant genome science — in which there is a great deal of innovation expected over the next five years. “It looks like Congress truly has their priorities in the right place,” Tullis said. �Copyright 2002, The Deal, LLC. All rights reserved.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.